Singapore markets open in 4 hours 42 minutes

Dyne Therapeutics, Inc. (DYN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
29.38+1.22 (+4.33%)
At close: 04:00PM EDT
29.38 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.46B
Enterprise value 2.03B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.15
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3107.52%
S&P500 52-week change 326.16%
52-week high 330.27
52-week low 36.40
50-day moving average 326.38
200-day moving average 316.47

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 3781.38k
Shares outstanding 587.38M
Implied shares outstanding 687.38M
Float 856.59M
% held by insiders 10.55%
% held by institutions 197.75%
Shares short (30 Apr 2024) 49.63M
Short ratio (30 Apr 2024) 411.31
Short % of float (30 Apr 2024) 413.51%
Short % of shares outstanding (30 Apr 2024) 411.02%
Shares short (prior month 28 Mar 2024) 48.08M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-40.98%
Return on equity (ttm)-71.50%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -264.21M
Net income avi to common (ttm)-257.4M
Diluted EPS (ttm)-3.98
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)453.55M
Total cash per share (mrq)5.19
Total debt (mrq)26.62M
Total debt/equity (mrq)5.57%
Current ratio (mrq)21.83
Book value per share (mrq)5.49

Cash flow statement

Operating cash flow (ttm)-219.79M
Levered free cash flow (ttm)-152.87M